ATE126437T1 - Verwendung von depogen zur behandlung von eingeschränktem blutkreislauf. - Google Patents

Verwendung von depogen zur behandlung von eingeschränktem blutkreislauf.

Info

Publication number: ATE126437T1
Authority: AT; Austria
Prior art keywords: depogen; blood circulation; diethoxy; restricted blood; treat
Prior art date: 1985-12-04

Application number

AT86309456T

Other languages

English (en)

Inventor

Peter Szentmiklosi

Istvan Hermecz

Zoltan Meszaros

Laszlo Tardos

Jeno Marton

Lelle Vasvari

Agnes Horvarth

Katalin Marmarosi

Original Assignee

Chinoin Gyogyszer Es Vegyeszet

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-12-04

Filing date

1986-12-04

Publication date

1995-09-15

1986-12-04 Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet

1995-09-15 Application granted granted Critical

1995-09-15 Publication of ATE126437T1 publication Critical patent/ATE126437T1/de

Links

OUKQYSCCWVCDKU-UHFFFAOYSA-N 1-[(3,4-diethoxyphenyl)methyl]-6,7-diethoxy-3,4-dihydroisoquinolin-2-ium;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetate Chemical compound O=C1N(C)C(=O)N(C)C2=C1N(CC(O)=O)C=N2.C1=C(OCC)C(OCC)=CC=C1CC1=NCCC2=CC(OCC)=C(OCC)C=C12 OUKQYSCCWVCDKU-UHFFFAOYSA-N 0.000 title abstract 3
230000017531 blood circulation Effects 0.000 title 1
239000008280 blood Substances 0.000 abstract 2
210000004369 blood Anatomy 0.000 abstract 2
239000003814 drug Substances 0.000 abstract 2
NCVXEYAKRVJMTQ-UHFFFAOYSA-N 1-[(3,4-diethoxyphenyl)methyl]-6,7-diethoxy-3,4-dihydroisoquinoline Chemical compound C1=C(OCC)C(OCC)=CC=C1CC1=NCCC2=CC(OCC)=C(OCC)C=C12 NCVXEYAKRVJMTQ-UHFFFAOYSA-N 0.000 abstract 1
210000004204 blood vessel Anatomy 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
External Artificial Organs (AREA)
Medicinal Preparation (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Solid-Sorbent Or Filter-Aiding Compositions (AREA)

AT86309456T 1985-12-04 1986-12-04 Verwendung von depogen zur behandlung von eingeschränktem blutkreislauf. ATE126437T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
HU854639A HU197207B (en)	1985-12-04	1985-12-04	Process for producing pharmaceutical comprising 1-(3',4'-diethoxybenzyl)-6,7-diethoxy-3,4-dihydro-isoquinolinium-theophylline-7-acetate or its monohydrate as active ingredient

Publications (1)

Publication Number	Publication Date
ATE126437T1 true ATE126437T1 (de)	1995-09-15

Family

ID=10968537

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT86309456T ATE126437T1 (de)	1985-12-04	1986-12-04	Verwendung von depogen zur behandlung von eingeschränktem blutkreislauf.

Country Status (6)

Country	Link
US (1)	US4814336A (de)
EP (1)	EP0227356B1 (de)
JP (1)	JPH0655672B2 (de)
AT (1)	ATE126437T1 (de)
DE (1)	DE3650368T2 (de)
HU (1)	HU197207B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HUT60926A (en) *	1991-04-12	1992-11-30	Chinoin Gyogyszer Es Vegyeszet	Process for producing pharmaceutical composition suitable for reducing or preventing increased thrombocyte-aggregation capability
HUT68560A (en) *	1993-08-02	1995-04-27	Chinoin Gyogyszer Es Vegyeszet	The use of xantine derivatives for promotion of healing of operative lesions
JP3276762B2 (ja) *	1993-12-28	2002-04-22	日本臓器製薬株式会社	イソキノリン誘導体を含有する医薬組成物
AU2009319348B2 (en) *	2008-11-27	2014-07-31	Lidds Ab	Use of carboxymethylcellulose to control ejectability and solidification of time of compositions one or more bioresorbable ceramics
BR112013029621A2 (pt) *	2011-05-20	2016-12-13	Chinoin Private Co Ltd	composição farmacêutica que compreende drotaverine

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1129134A (en) *	1964-11-04	1968-10-02	Sterling Winthrop Group Ltd	Improvements in compositions containing nicotinates
FR4135M (de) *	1965-01-19	1966-05-02
DE1492203A1 (de) *	1965-12-29	1970-01-15	Thomae Gmbh Dr K	Verfahren zur Herstellung von stabilen Loesungen des Theophyllins
FR2181717B1 (de) *	1968-11-25	1976-11-05	Albert Ag Chem Werke
FR2202686A1 (en) *	1972-10-13	1974-05-10	Fabre Sa Pierre	Nicotinyl theophylline acetate hydrochloride - ingredient in medicaments for circulatory disorders and dyslipemia
HU167246B (de) *	1973-01-25	1975-09-27
FR2279394A2 (fr) *	1973-12-13	1976-02-20	Saunier Laboratoires	Medicament pour le traitement des insuffisances circulatoires cerebrales
US4364922A (en) *	1980-10-14	1982-12-21	University Of Virginia Alumni Patents Foundation	Adenosine antagonists in the treatment and diagnosis of A-V node conduction disturbances
US4383997A (en) *	1980-11-26	1983-05-17	Boucher John H	Method of treating horses to inhibit or reduce increases in crenated red blood cells during exercise

1985
- 1985-12-04 HU HU854639A patent/HU197207B/hu not_active IP Right Cessation
1986
- 1986-12-03 JP JP61288646A patent/JPH0655672B2/ja not_active Expired - Lifetime
- 1986-12-03 US US06/937,536 patent/US4814336A/en not_active Expired - Fee Related
- 1986-12-04 EP EP86309456A patent/EP0227356B1/de not_active Expired - Lifetime
- 1986-12-04 DE DE3650368T patent/DE3650368T2/de not_active Expired - Fee Related
- 1986-12-04 AT AT86309456T patent/ATE126437T1/de not_active IP Right Cessation

Also Published As

Publication number	Publication date
HUT42940A (en)	1987-09-28
EP0227356A3 (en)	1989-12-13
DE3650368T2 (de)	1996-01-18
EP0227356B1 (de)	1995-08-16
HU197207B (en)	1989-03-28
EP0227356A2 (de)	1987-07-01
JPH0655672B2 (ja)	1994-07-27
JPS62187411A (ja)	1987-08-15
DE3650368D1 (de)	1995-09-21
US4814336A (en)	1989-03-21

Similar Documents

Publication	Publication Date	Title
DE3587941D1 (de)	1994-12-01	Gerät zur vorläufigen reperfusionsbehandlung von herzanfallsymptomen.
FI875533A0 (fi)	1987-12-16	Insulinpreparat foer non-parenteral dosering.
DE69230112D1 (de)	1999-11-11	Fortschrittliches arzneistoffabgabesystem und verfahren zur behandlung von psychiatrischen, neurologischen und anderen erkrankungen mit carbamazepin
SE9401406L (sv)	1994-06-07	Farmaceutiska produkter för att bota tumörsjukdomar samt förfarande för framställning av desamma
ES2000428T3 (es)	1993-10-01	Procedimiento para producir un medicamento para el tratamiento de la enfermedad de alzheimer, que contiene galantamina, y dispositivo medico correspondiente.
ATE65505T1 (de)	1991-08-15	Biologisch aktive fragmente von humanem antihaemophiliefaktor, methode zu ihrer herstellung und pharmazeutische praeparate.
DE68909409D1 (de)	1993-10-28	Heilmitteldosierung zur verabreichung an fische.
ATA91797A (de)	1999-01-15	Eine das vwf-propeptid enthaltende pharmazeutische präparation
DE58901002D1 (de)	1992-04-30	Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken.
DE3682229D1 (de)	1991-12-05	Zur stimulierung der traenensekretion verwendbare pharmazeutische praeparate.
PT86346A (en)	1988-01-01	Method of treatment by means of the 3:-deoxitimidinene-2:(3:deoxi-2:3:-didesidrotimidine) administration to animals of hot blood infected with retrovirus
ATE80039T1 (de)	1992-09-15	Pharmazeutische zusammensetzung, enthaltend 2',3'-dideoxycytidin-2'-en(2',3'-dideoxy-2',3'didehydrocytidin) zur behandlung von mit retrovirus infizierten patienten.
BG44709A3 (bg)	1989-01-16	Метод за получаване на 9-хлор-1,5-бензотиазепинови производни
ATE126437T1 (de)	1995-09-15	Verwendung von depogen zur behandlung von eingeschränktem blutkreislauf.
IT8721115A0 (it)	1987-06-30	Fitopreparato per la cura di affezioni cutanee.
ATE25969T1 (de)	1987-04-15	1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan zur verwendung bei der bekaempfung von krankheiten.
DE3380923D1 (de)	1990-01-11	Pharmazeutische zusammensetzungen zur behandlung von stoerungen, bedingt durch humanendrogen.
DE3876425D1 (de)	1993-01-14	Gesteuerte verabreichung eines heilmittels an blut.
DK0499679T3 (da)	1996-02-05	Terapeutisk middel til diabetisk gangræn
DE3280419D1 (de)	1992-11-26	Medizinisches praeparat zur behandlung von hautleiden.
GR3006147T3 (de)	1993-06-21
DE3772047D1 (de)	1991-09-12	Pyrazin zur behandlung von haemodynamischen und metabolischen krankheiten.
DK417889A (da)	1990-02-25	Anvendelse af 2-azabicyklo(2.2.2.)-carboxylsyrederivater til fremstilling af medicinske produkter til behandling af vaskulaere sygdomme
FI851969A7 (fi)	1985-11-18	Korkean verenpaineen hoitoon soveltuvia tetrahydronaftalenoleja.
RO94684A2 (ro)	1989-05-30	Medicament pentru tratamentul unor dermatoze

Legal Events

Date	Code	Title	Description
1996-03-15	UEP	Publication of translation of european patent specification
1997-09-15	REN	Ceased due to non-payment of the annual fee